Clinicians underutilize RSV testing in adults with respiratory or cardiac exacerbations, potentially obscuring the true burden of disease.

"We found that residents of these facilities suffered significantly greater morbidity and mortality from RSV infections compared with older adults living in the community." — Brenda L. Tesini, MD, ...

This week in JAMA Network Open, a team led by researchers from respiratory syncytial virus (RSV) vaccine-maker Pfizer ...

RSV vaccination for adults aged 60+ could prevent significant LRTD cases, hospitalizations, and deaths over five years. A 5-percentage-point increase in vaccine uptake could avert over 222,000 LRTD ...

Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60. The vaccine candidates, made by ...

RSV, or respiratory syncytial virus, can hit adults hard. Though it usually feels like a cold, with symptoms clearing up within a couple weeks, the virus can lead to more serious lung infections in ...

Tony Wood, Chief Scientific Officer, GSK: “We are pleased with ACIP's recommendation to expand the benefits of RSV immunization to more than 13 million adults aged 50-59 who are at increased risk for ...

RSV is a rapidly spreading virus that infects the lungs and respiratory tract. It spreads through coughs, sneezes, or close ...

While monoclonal antibodies have been approved to treat respiratory syncytial virus (RSV) in infants and young children in Germany, the German regulatory body for vaccinations—the German National ...

Whether you, your grandma, or your 6-month-old niece get a cold, chances are, you’ll all feel pretty much the same (mildly rotten). But with respiratory syncytial virus, or RSV, how old you are can ...